KR890004736A - 다공성 삼투 조절 펌프 - Google Patents

다공성 삼투 조절 펌프 Download PDF

Info

Publication number
KR890004736A
KR890004736A KR1019880012295A KR880012295A KR890004736A KR 890004736 A KR890004736 A KR 890004736A KR 1019880012295 A KR1019880012295 A KR 1019880012295A KR 880012295 A KR880012295 A KR 880012295A KR 890004736 A KR890004736 A KR 890004736A
Authority
KR
South Korea
Prior art keywords
osmotic pump
diltiazem
maleate
site
therapeutically effective
Prior art date
Application number
KR1019880012295A
Other languages
English (en)
Other versions
KR970007190B1 (ko
Inventor
엘.하슬람 존
에스.로크 제랄드
Original Assignee
제임스 에프.너톤
머크 앤드 캄파니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/100,676 external-priority patent/US4886668A/en
Priority claimed from US07/100,665 external-priority patent/US4880631A/en
Application filed by 제임스 에프.너톤, 머크 앤드 캄파니, 인코포레이티드 filed Critical 제임스 에프.너톤
Publication of KR890004736A publication Critical patent/KR890004736A/ko
Application granted granted Critical
Publication of KR970007190B1 publication Critical patent/KR970007190B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)

Abstract

내용 없음

Description

다공성 삼투 조절 펌프
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 삼투 펌프의 한 양태를 나타낸 것이다.
제2도는 실시예 1에서 제조된 펌프의 방출 양상(몇몇 펌프의 통계학적 평균값)을 나타낸 것이다.
제3도는 실시예 2에서 제조된 펌프의 방출 양상(몇몇 펌프의 통계학적 평균값)을 타나낸 것이다.

Claims (10)

  1. [A]치료 유효량의 딜티아젬 L-말레이트 및 효과적 완충량의 나트륨 비타르트레이트를 함유하는 핵정, [B]이 핵정을 둘러싸고 있으며, (i) 수투과성이나 용질 불투과성인 중합체 및 (ii) 벽전체에 고루 분산된 pH1 이상에서는 민감하지 않은, (i) 과 (ii)의 총중량을 기본으로 0.1 내지 60중량%의 세공 형성 첨가제로부터 제조되어 6.96×10-18내지 6.96×10-14cm3sec/g의 유체 투과도 및 0.5 이하의 굴절 게수를 갖는 수불용성 속도조절벽으로 이루어짐을 특징으로 하는, 사용부위의 주변에의 딜티아젬 L-말레이트의 방출 조절용 삼투 펌프.
  2. (I) 사용부위의 주변에서는 통합성이 유지되지 않는 담체 매질 및(II) 제1항에 따른 삼투 펌프로 구성된 다수의 작은 삼투 펌프 요소로 이루어짐을 특징으로 하는 사용 부위의 주변에의 딜티아젬 L-말레이트의 방출 조절용 다수입자 삼투 펌프.
  3. 제1항 또는 2항에 있어서, 딜티아젬 L-말레이트가 80 내지 150중량%의 나트륨 비타르트레이트와 배합되는 삼투 펌프.
  4. 제3항에 있어서, 핵정중의 딜티아젬 L-멜라이트가 30 내지 500mg인 삼투 펌프.
  5. 제3항에 있어서, 핵정중의 나트륨 비타르트 레이트가 30 내지 500mg인 삼투 펌프.
  6. 제1항에 있어서, 굴절 계수가 0.1미만인 삼투 펌프.
  7. 제1 또는 2항에 있어서, 매질내의 치료 유효량의 심장 혈관용 약제 및 약제학적으로 허용되는 담체로 이루어진 추가의 펠렛 또는 다수입자; 또는 작은 삼투 펌프 요소상의 약제학적으로 허용되는 담체 및 치료 유효량의 심장 혈관용 약제로 이루어진 외층을 함유함을 특징하는 삼투 펌프.
  8. 제7항에 있어서, 심장 혈관용 약제가 안지오텐신 전환 효소 억제제로부터 선택되는 삼투 펌프.
  9. 제8항에 있어서, 안지오텐신 전환 효소 억제제가 캅토프릴, 에날라프릴 및 리시노프릴로부터 선택되는 삼투 펌프.
  10. 제9항에 있어서, 고체 담체 매질이 고체 가용성 젤라틴 캡슐 또는 고체 정제 매트릭스인 삼투 펌프.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880012295A 1987-09-24 1988-09-23 서방출되는 다공성 삼투 펌프 KR970007190B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US100,676 1987-09-24
US07/100,676 US4886668A (en) 1987-09-24 1987-09-24 Multiparticulate controlled porosity osmotic pump
US100,665 1987-09-24
US07/100,665 US4880631A (en) 1987-09-24 1987-09-24 Controlled porosity osmotic pump

Publications (2)

Publication Number Publication Date
KR890004736A true KR890004736A (ko) 1989-05-09
KR970007190B1 KR970007190B1 (ko) 1997-05-07

Family

ID=26797417

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012295A KR970007190B1 (ko) 1987-09-24 1988-09-23 서방출되는 다공성 삼투 펌프

Country Status (15)

Country Link
EP (1) EP0309051B1 (ko)
JP (1) JP2610316B2 (ko)
KR (1) KR970007190B1 (ko)
AU (1) AU604564B2 (ko)
CA (1) CA1320885C (ko)
DE (1) DE3869032D1 (ko)
DK (1) DK529188A (ko)
ES (1) ES2039275T3 (ko)
GR (1) GR3004364T3 (ko)
HK (1) HK47493A (ko)
IE (1) IE62747B1 (ko)
IL (1) IL87756A (ko)
NZ (1) NZ226179A (ko)
PT (1) PT88566B (ko)
SG (1) SG16393G (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5728088A (en) * 1988-12-13 1998-03-17 Alza Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
WO1994022424A1 (en) * 1993-03-29 1994-10-13 Alza Corporation Biodegradable, water-permeable membrane for fluid-imbibing pump
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
BR0306928A (pt) * 2002-01-15 2004-11-09 Ranbaxy Lab Ltd Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
US8236349B2 (en) 2004-04-12 2012-08-07 Bend Research Inc. Taste-masked drugs in rupturing multiparticulates
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
EP2091519B1 (en) 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
CN101766581B (zh) * 2008-12-30 2012-08-15 北京科信必成医药科技发展有限公司 一种群孔释放的盐酸地尔硫卓择时控释片及其制备方法
JP2011242408A (ja) * 2011-08-04 2011-12-01 Collagen Gijutsu Kenshukai Kk 抗ゼラチン抗体の測定法
CN107569469B (zh) * 2017-09-21 2021-01-08 浙江省医学科学院 一种石杉碱甲渗透泵缓释微丸胶囊及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
DE3310843C2 (de) * 1983-03-25 1986-02-13 Albrecht Prof. Dr.med. 7801 Bollschweil Fleckenstein Verwendung von Diltiazem, bei der Prophylaxe und Behandlung von nikotinbedingten Schäden der Herz- und Gefäßmuskulatur
CA1266827A (en) * 1984-06-20 1990-03-20 Merck & Co., Inc. Controlled porosity osmotic pump
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.

Also Published As

Publication number Publication date
KR970007190B1 (ko) 1997-05-07
JP2610316B2 (ja) 1997-05-14
IL87756A0 (en) 1989-02-28
EP0309051B1 (en) 1992-03-11
DK529188A (da) 1989-05-18
AU604564B2 (en) 1990-12-20
IE62747B1 (en) 1995-02-22
IE882899L (en) 1989-03-24
GR3004364T3 (ko) 1993-03-31
DE3869032D1 (de) 1992-04-16
PT88566A (pt) 1988-10-01
DK529188D0 (da) 1988-09-23
JPH01128927A (ja) 1989-05-22
ES2039275T3 (es) 1993-09-16
HK47493A (en) 1993-05-21
PT88566B (pt) 1993-04-30
NZ226179A (en) 1991-04-26
CA1320885C (en) 1993-08-03
SG16393G (en) 1993-04-16
AU2277388A (en) 1989-04-06
IL87756A (en) 1992-12-01
EP0309051A1 (en) 1989-03-29

Similar Documents

Publication Publication Date Title
KR890004736A (ko) 다공성 삼투 조절 펌프
DE69331806D1 (de) Multipartikel-arzneistoffabgabesystem mit stossweiser freisetzung
MX9301733A (es) Microcapsulas de liberacion controlada.
ATE79029T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe.
KR850002954A (ko) 젤라틴 캡슐
DK276585A (da) Osmotisk pumpe
NZ511448A (en) A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
AR019933A1 (es) Granulos que tienen un nucleo recubierto con un agente antifungico y un polimero, un procedimiento para su preparacion, una forma de dosificacionfarmaceutica
JPS56156212A (en) Surface treating method of soft capsule agent
JPS5349050A (en) Gas barrier film
PT946150E (pt) Preparado oral que contem numa matriz que pode intumescer-se num meio aquoso pelo menos uma substancia activa farmaceutica
FR2863097B1 (fr) Assemblage de combustible pour reacteur nucleaire a eau pressurisee contenant de l'uranium enrichi sans plutonium.
Lampert Experiments on the resistance of fish to rapid increase in hydrostatic pressure
Williams et al. White Pelican
Speth et al. The Natural Resources of Anaheim Bay--Huntington Harbour. Report Number 18 on California Coastal Wetlands
Patten Integrating Science and Decision Making Duncan Patten
JPS56147685A (en) Treatment for liquid to be treated by fixed-bed contact oxidation tank
JPS574918A (en) Material for feeding physiologically active substance
JPS5685011A (en) Controlling method for flow rate of river water
JPS55129511A (en) Permeable offshore bank
JPS52458A (en) Liquid level gauge
JPS5437927A (en) Liquid fuel burner
Koester et al. Reconnaisance investigations of Po-210 and other natural radionuclides in Dutch coastal ecosystems.]
JPS51146673A (en) Low-level of fluid alarm of reservoir
Weinhold Erosion in clay-core dams; stability evaluation and options for remedial works

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030718

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee